share_log

60 Degrees Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities- Knight Therapeutics Inc

60 Degrees Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

60 Degrees Pharmaceuticals | 4：持股變動聲明
美股sec公告 ·  04/04 06:04
牛牛AI助理已提取核心訊息
Knight Therapeutics Inc, a former 10% owner of 60 Degrees Pharmaceuticals, has engaged in a planned transaction on July 28, 2023. The transaction involved the acquisition of 45,560 shares of common stock at a price of $4.745 per share and the disposal of 2,162 shares of Series A Non-Voting Convertible Preferred Stock at no cost. Following these transactions, Knight Therapeutics Inc's indirect beneficial ownership, through Knight Therapeutics International S.A., will amount to 78,803 shares of 60 Degrees Pharmaceuticals.
Knight Therapeutics Inc, a former 10% owner of 60 Degrees Pharmaceuticals, has engaged in a planned transaction on July 28, 2023. The transaction involved the acquisition of 45,560 shares of common stock at a price of $4.745 per share and the disposal of 2,162 shares of Series A Non-Voting Convertible Preferred Stock at no cost. Following these transactions, Knight Therapeutics Inc's indirect beneficial ownership, through Knight Therapeutics International S.A., will amount to 78,803 shares of 60 Degrees Pharmaceuticals.
Knight Therapeutics Inc曾是60 Degrees Pharmicals的10％所有者，已計劃於2023年7月28日進行一項交易。該交易涉及以每股4.745美元的價格收購45,560股普通股，以及免費出售2,162股A系列無表決權可轉換優先股。這些交易之後，Knight Therapeutics Inc通過奈特療法國際股份有限公司獲得的間接實益所有權將達到60 Degrees Pharmicals的78,803股股份。
Knight Therapeutics Inc曾是60 Degrees Pharmicals的10％所有者，已計劃於2023年7月28日進行一項交易。該交易涉及以每股4.745美元的價格收購45,560股普通股，以及免費出售2,162股A系列無表決權可轉換優先股。這些交易之後，Knight Therapeutics Inc通過奈特療法國際股份有限公司獲得的間接實益所有權將達到60 Degrees Pharmicals的78,803股股份。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。